Harris Eyre

Last updated

Harris Eyre is an Australian neuroscientist, entrepreneur, economic strategist and author. [1] [2] [3] [4] He is focused on advancing the brain economy, aka the brain-positive economic transformation, to stop and reverse the loss of global brain capital. [5] [6] [7] It is believed the world is increasingly relying on brain capital, where a premium is put on brain skills and brain health (e.g., individual’s cognitive, emotional, and social brain resources), [8] and that investing in building brain capital is fundamental to meet modern societal challenges and to drive innovation. [9]

Contents

He is a former Forbes 30 Under 30 Asia Listmaker [10] and UCLA Fulbright Scholar. [11]

In his work, he incorporates insights from precision medicine, [12] clinical care, [13] entrepreneurship, [14] convergence science, [15] consumer participation, [16] workforce development, [17] economics, [18] public policy [19] and diplomacy. [20]

Eyre is a migraineur and recently wrote a short story titled "My migraines are a super power" for the European Federation of Neurological Associations. [21] [22]

Education

Eyre grew up in Mackay, Queensland, Australia [23] , attended the Whitsunday Anglican School where he was awarded the 2024 Young Old Scholar Award. [24] He completed his undergraduate medical degree (Bachelor of Medicine, Bachelor of Surgery (MBBS) with Honours) at James Cook University in North Queensland, Australia, where he was awarded the 2017 Early Career Alumni Award. [25] His medical education specialized in rural, remote, Indigenous and tropical health. [26] He then completed his PhD in neuroscience at the University of Adelaide. [27] During his PhD, he was awarded the W.G. Walker Fulbright Scholarship to study at UCLA. [28] The W.G. Walker Fulbright Scholarship is awarded to the top Australian Fulbright Scholar annually. [29]

Career

Think tanks

Eyre works with leading think tanks including the Center for Health and Biosciences at The Baker Institute for Public Policy at Rice University, [30] the Meadows Mental Health Policy Institute, [31] the Euro-Mediterranean Economists Association, [32] The Brookings Institution, [33] the Center for European Policy Studies [34] , and the Global Brain Health Institute. [35]

Convergence Mental Health

Eyre is the lead editor of 'Convergence Mental Health: A Roadmap Towards Transdisciplinary Innovation' with Oxford University Press. [36] The book description as outlined on the Oxford University Press website reads "Modern mental health issues are characterized by their complex, multi-systemic nature and broad societal impact, making them poorly suited to siloed approaches of thinking and innovation. Convergence science integrates knowledge, tools, and thought strategies from various fields and is the focal point where novel insights arise. Convergence Mental Health presents a blueprint for leveraging convergence science within the context of mental health in order to improve patient outcomes and health care systems." [36]

This book includes contributions from organizations including the Milken Institute, APEC, OECD, Harvard University, Stanford University and the Mayo Clinic. [36]

Notable chapter contributors include Julio Licinio, Vikram Patel and Reid Hoffman. [37]

Notable quotes of support come from Jeff Cummings, John Arnold, Peter C Farrell, Victor Dzau and Ernestine Fu. [37]

Brain Economy

The brain economy model recognizes solving brain health challenges will require major transitions across most major sectors. [38] Each of these is complex and will require a systems approach. Incremental change will not be sufficient and there are few silver bullets. No single technology, policy, or actor alone can achieve these critical shifts. Rather, it will take a community of people working together across systems to employ innovative solutions and accelerate change.

Eyre is leading the development of the Brain Capital Grand Strategy. [39] [40] [41] This includes exploring and actioning Brain Capital in-all-policies, articulating and actioning the Brain Capital Investment Plan, [42] and developing a Brain Capital Index.

He co-led the OECD Neuroscience-inspired Policy Initiative. [43] This Initiative sought to advance brain-based policy and investment innovations. On January 27, 2021, the OECD held a Brain Capital Event on this topic. [44] Notable speakers included Angel Gurria (OECD Secretary General), Admiral William H McRaven, Thomas C Leppert, Megan Greene and Francesca Colombo. [44] On March 26, 2021, the OECD held an event titled 'Innovations to Address Women’s Brain Health Inequalities'. [45] Notable speakers included Juan Yermo (OECD Chief of Staff), Maureen Hackett, Antonella Santuccione, Sofia Noori, Sandra Bond Chapman and Megan Green. [45] On June 10, 2021, the OECD held an event titled 'Rethinking Productivity: Insights from Neuroscience'. [46] Notable speakers included George Vradenburg, Andy Keller, Husseini K Manji, Chiara Crisculo and Andrew S Nevin. [47]

He leads the Brain Capital Alliance. [48] This is an expanded, multi-national and multi-organisational programme.

Brain capital has been profiled in the following policy innovation fora:

- World Economic Forum [49]

- United Nations General Assembly [50]

- Wharton Neuroscience Initiative Summit [51]

- Women in Government Leadership and Innovation Summit [52]

- FENS Forum [53]

- Congressional Neuroscience Caucus [54]

- US House Select Committee on Economic Disparity and Fairness in Growth [55]

- Lundbeck position statement on brain health [56]

- WHO position statement on brain health [57]

- Brookings Policy Paper proposing a White House Brain Capital Council [19]

- European Brain Initiative [58]

- United Nations Development Programme Human Development Report [59]

- PwC [60]

Eyre is an advisor to the University of Sydney's Mental Wealth Initiative (MWI). [61] Notable members of the MWI Advisory Panel include former Australian Prime Minister, the Hon. Malcolm Turnbull, Businesswoman, Lucy Turnbull, AO, Economist and Lawyer, Professor Allan Fels, AO, economist and former Labor Party politician, the Hon. Dr Craig Emerson, and World Bank economist, Professor William Hynes.

Brain Capital Industrial Innovation Strategy

A global coalition of authors recently published on this strategy by a Rice University Baker Institute for Public Policy Research Paper titled '7 Steps for Igniting the Brain Capital Industrial Strategy'. This is a public private strategy that focuses on building economic resilience through an emphasis on cultivating citizens’ brain health and brain skills to contribute to an innovative and thriving economy. This strategy outlines how governments, academia and the private sector need to unite to tackle this goal of improving our brain function and enhancing our potential. Funding initiatives, research partnerships and open dialogue will be critical to drive this movement forward. By championing an industry focused on improving brain function, the authors argue that we have the chance to reshape industries, enhance lives and shape a future that works for people’s brains.

Industry

Eyre has held a number of industry positions during his career. He was an advisor to the HEKA Fund, a brain capital-focused venture fund which is a collaboration between Newfund Capital and FondaMental Fondation. [62] He was president and chief medical officer of PRODEO, a group of brain health-focused executives. [63] He co-founded The PRODEO Institute, a think-tank focused on radically approaches to advancing brain health. [64]

In 2015, Eyre was announced as Co-Founder and Chief Medical Officer of CNSdose, a company focused on personalized medication guidance. [65] [66] CNSdose is noted for incorporating blood-brain-barrier genetics into their tool and publishing a Randomized Controlled Trial. [67] [68] In 2016, the US Department of Veterans Affairs Health Administration noted CNSdose technology as "the most promising in an early field." [69] CNSdose is a Texas Medical Center Venture Fund Portfolio Company. [70] CNSdose completed the Melbourne Accelerator Program in 2016. [71] When Eyre was Chief Medical Officer, the non-executive chairman was Hon Andrew Robb AO (former Trade and Investment Minister of Australia). [72] As Chief Medical Officer, Eyre worked in successful teams to secure a major commercial contract with Intermountain Healthcare [73] and independent funding for a large, multi-side RCT with Ramsay Health Care. [74] While he was with CNSdose, he was heavily involved in scientific collaborations with global experts. [75] [76]

Academia

Eyre published 190 + articles and chapters,. [77]

In his research career, he has co-authored numerous works including the 'Brain Capital Grand Strategy', [39] 'B rain Capital Industrial Innovation Policy' , 'Comprehensive Brain Deal' [78] 'Green Brain Capital', [79] 'Neuroshield', [80] 'Brain Health Executive', [81] 'Sleep Diplomacy', ‘Responsible Innovation in Mental Health ’, [82] 'Brain-based Stakeholder Capitalism', [83] 'Brain Health Gap', [84] 'Measurement-based Cognitive Care', [85] ‘Mental Health Innovation Diplomacy’ , [86] the 'Brain Health Diplomacy' model, [87] the 'Mars Mental Health' model, [88] the 'Phase-specific Neuroimmune Model of Depression', [89] a meta-analysis of chemokines in depression, [90] a meta-analysis of pharmacogenetic-based decision support tools for depression, [91] a randomized controlled trial of yoga to prevent dementia [92] and the model of 'Convergence Psychiatry'. [15]

He maintains advisory roles with Baylor College of Medicine, [93] Houston Methodist, the Davos Alzheimer's Collaborative. [94] and the Latin American Brain Health Institute. [95]

Public and media appearances

His academic work has been profiled in The New York Times, [96] the Financial Post, [97] [98] neo.life, [99] STAT, [100] the Australian Financial Review, [101] the 'Financial Times', [102] Univision, [103] Dallas Morning News [104] and Les Echos. [105]

Awards

Eyre has been awarded various awards throughout his career including:

Works

Select research articles

Selected commentaries

Related Research Articles

<span class="mw-page-title-main">Bipolar disorder</span> Mental disorder that causes periods of depression and abnormally elevated mood

Bipolar disorder, previously known as manic depression or manic depressive disorder, is a mental disorder characterized by periods of depression and periods of abnormally elevated mood that each last from days to weeks. If the elevated mood is severe or associated with psychosis, it is called mania; if it is less severe and does not significantly affect functioning, it is called hypomania. During mania, an individual behaves or feels abnormally energetic, happy, or irritable, and they often make impulsive decisions with little regard for the consequences; there is usually also a reduced need for sleep during manic phases. During periods of depression, the individual may experience crying, have a negative outlook on life, and demonstrate poor eye contact with others. The risk of suicide is high; over a period of 20 years, 6% of those with bipolar disorder died by suicide, while 30–40% engaged in self-harm. Other mental health issues, such as anxiety disorders and substance use disorders, are commonly associated with bipolar disorder. The global prevalence of bipolar disorder is estimated to be between 1-5% of the world's popluation.

A mental disorder, also referred to as a mental illness, a mental health condition, or a psychiatric disability, is a behavioral or mental pattern that causes significant distress or impairment of personal functioning. A mental disorder is also characterized by a clinically significant disturbance in an individual's cognition, emotional regulation, or behavior, often in a social context. Such disturbances may occur as single episodes, may be persistent, or may be relapsing–remitting. There are many different types of mental disorders, with signs and symptoms that vary widely between specific disorders. A mental disorder is one aspect of mental health.

<span class="mw-page-title-main">Mania</span> State of abnormally elevated or irritable mood, arousal, and/or energy levels

Mania, also known as manic syndrome, is a psychiatric behavioral syndrome defined as a state of abnormally elevated arousal, affect, and energy level. During a manic episode, an individual will experience rapidly changing emotions and moods, highly influenced by surrounding stimuli. Although mania is often conceived of as a "mirror image" to depression, the heightened mood can be dysphoric as well as euphoric. As the mania intensifies, irritability can be more pronounced and result in anxiety or anger.

<span class="mw-page-title-main">Schizophrenia</span> Mental disorder with psychotic symptoms

Schizophrenia is a mental disorder characterized by hallucinations, delusions, disorganized thinking and behavior, and flat or inappropriate affect. Symptoms develop gradually and typically begin during young adulthood and are never resolved. There is no objective diagnostic test; diagnosis is based on observed behavior, a psychiatric history that includes the person's reported experiences, and reports of others familiar with the person. For a diagnosis of schizophrenia, the described symptoms need to have been present for at least six months or one month. Many people with schizophrenia have other mental disorders, especially mood disorders, anxiety disorders, and obsessive–compulsive disorder.

<span class="mw-page-title-main">Dementia</span> Long-term brain disorders causing impaired memory, thinking and behavior

Dementia is a syndrome associated with many neurodegenerative diseases, characterized by a general decline in cognitive abilities that affects a person's ability to perform everyday activities. This typically involves problems with memory, thinking, behavior, and motor control. Aside from memory impairment and a disruption in thought patterns, the most common symptoms of dementia include emotional problems, difficulties with language, and decreased motivation. The symptoms may be described as occurring in a continuum over several stages. Dementia ultimately has a significant effect on the individual, their caregivers, and their social relationships in general. A diagnosis of dementia requires the observation of a change from a person's usual mental functioning and a greater cognitive decline than might be caused by the normal aging process.

Outpatient commitment—also called assisted outpatient treatment (AOT) or community treatment orders (CTO)—refers to a civil court procedure wherein a legal process orders an individual diagnosed with a severe mental disorder to adhere to an outpatient treatment plan designed to prevent further deterioration or recurrence that is harmful to themselves or others.

<span class="mw-page-title-main">Electroconvulsive therapy</span> Medical procedure in which electrical current is passed through the brain

Electroconvulsive therapy (ECT) or electroshock therapy (EST) is a psychiatric treatment during which a generalized seizure is electrically induced to manage refractory mental disorders. Typically, 70 to 120 volts are applied externally to the patient's head, resulting in approximately 800 milliamperes of direct current passing between the electrodes, for a duration of 100 milliseconds to 6 seconds, either from temple to temple or from front to back of one side of the head. However, only about 1% of the electrical current crosses the bony skull into the brain because skull impedance is about 100 times higher than skin impedance.

<span class="mw-page-title-main">Causes of mental disorders</span> Etiology of psychopathology

A mental disorder is an impairment of the mind disrupting normal thinking, feeling, mood, behavior, or social interactions, and accompanied by significant distress or dysfunction. The causes of mental disorders are very complex and vary depending on the particular disorder and the individual. Although the causes of most mental disorders are not fully understood, researchers have identified a variety of biological, psychological, and environmental factors that can contribute to the development or progression of mental disorders. Most mental disorders result in a combination of several different factors rather than just a single factor.

A psychiatric or psychotropic medication is a psychoactive drug taken to exert an effect on the chemical makeup of the brain and nervous system. Thus, these medications are used to treat mental illnesses. These medications are typically made of synthetic chemical compounds and are usually prescribed in psychiatric settings, potentially involuntarily during commitment. Since the mid-20th century, such medications have been leading treatments for a broad range of mental disorders and have decreased the need for long-term hospitalization, thereby lowering the cost of mental health care. The recidivism or rehospitalization of the mentally ill is at a high rate in many countries, and the reasons for the relapses are under research.

<span class="mw-page-title-main">Attention deficit hyperactivity disorder</span> Neurodevelopmental disorder

Attention-deficit/hyperactivity disorder (ADHD) or hyperkinetic disorder (HD), is a neurodevelopmental disorder characterized by executive dysfunction occasioning symptoms of inattention, hyperactivity, impulsivity and emotional dysregulation that are excessive and pervasive, impairing in multiple contexts, and developmentally-inappropriate.

Helen S. Mayberg, is an American neurologist. Mayberg is known in particular for her work delineating abnormal brain function in patients with major depression using functional neuroimaging. This work led to the first pilot study of deep brain stimulation (DBS), a reversible method of selective modulation of a specific brain circuit, for patients with treatment-resistant depression. As of August 2019, she has published 211 original peer-reviewed articles, 31 books and book chapters, and acted as principal investigator on 24 research grants. Mayberg is coinventor with Andres Lozano of “Method for Treating Depression Mood Disorders and Anxiety Disorders using Neuromodulation,” US patent 2005/0033379A1. St. Jude Medical Neuromodulation licensed her intellectual property to develop Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Unipolar and Bipolar Depression for the treatment of severe depression. As of 2018, Mayberg holds positions as Professor of Neurology and Neurosurgery and Professor, Psychiatry and Neuroscience, both at Mount Sinai Medical School, and Professor of Psychiatry, Emory University; Emory University Hospital. Since 2018, she has served as Director, Nash Family Center for Advanced Circuit Therapeutics at the Icahn School of Medicine at Mount Sinai.

The Journal of Medical Internet Research is a peer-reviewed open-access medical journal established in 1999 covering eHealth and "healthcare in the Internet age". The editors-in-chief are Gunther Eysenbach and Rita Kukafka. The publisher is JMIR Publications.

Child and adolescent psychiatry is a branch of psychiatry that focuses on the diagnosis, treatment, and prevention of mental disorders in children, adolescents, and their families. It investigates the biopsychosocial factors that influence the development and course of psychiatric disorders and treatment responses to various interventions. Child and adolescent psychiatrists primarily use psychotherapy and/or medication to treat mental disorders in the pediatric population.

Jeffrey H. Meyer is a scientist and professor working with mood and anxiety disorders using neuroimaging at the Department of Psychiatry, University of Toronto. He is currently the head of the Neurochemical Imaging Program in Mood and Anxiety Disorders in the Brain Health Imaging Centre at the Campbell Family Mental Health Research Institute and is working as a Senior Scientist in the General and Health Systems Psychiatry Division at the Centre for Addiction and Mental Health. He has also been awarded with the Tier 1 Canada Research Chair in the Neurochemistry of Major Depression.

<span class="mw-page-title-main">Psychiatry</span> Branch of medicine devoted to mental disorders

Psychiatry is the medical specialty devoted to the diagnosis, prevention, and treatment of deleterious mental conditions. These include various matters related to mood, behaviour, cognition, perceptions, and emotions.

<span class="mw-page-title-main">Patrick McGorry</span> Australian psychiatrist

Patrick Dennistoun McGorry is an Irish-born Australian psychiatrist known for his development of the early intervention services for emerging mental disorders in young people.

Psychiatry is, and has historically been, viewed as controversial by those under its care, as well as sociologists and psychiatrists themselves. There are a variety of reasons cited for this controversy, including the subjectivity of diagnosis, the use of diagnosis and treatment for social and political control including detaining citizens and treating them without consent, the side effects of treatments such as electroconvulsive therapy, antipsychotics and historical procedures like the lobotomy and other forms of psychosurgery or insulin shock therapy, and the history of racism within the profession in the United States.

<span class="mw-page-title-main">Jeffrey Swanson</span> American medical sociologist

Jeffrey W. Swanson is an American medical sociologist and professor in psychiatry and behavioral sciences at Duke University School of Medicine. He is an expert in psychiatric epidemiology, especially as regards the epidemiology of violence and serious mental illness.

<span class="mw-page-title-main">Carolyn M. Mazure</span> American psychiatrist

Carolyn M. Mazure is an American psychologist and the Norma Weinberg Spungen and Joan Lebson Bildner Professor of Psychiatry and Psychology at the Yale School of Medicine. She created and directs Women’s Health Research at Yale — Yale’s interdisciplinary research center on health and gender.

<span class="mw-page-title-main">Mental health during the COVID-19 pandemic</span> Psychological aspect of viral outbreak

The COVID-19 pandemic has impacted the mental health of people across the globe. The pandemic has caused widespread anxiety, depression, and post-traumatic stress disorder symptoms. According to the UN health agency WHO, in the first year of the COVID-19 pandemic, prevalence of common mental health conditions, such as depression and anxiety, went up by more than 25 percent. The pandemic has damaged social relationships, trust in institutions and in other people, has caused changes in work and income, and has imposed a substantial burden of anxiety and worry on the population. Women and young people face the greatest risk of depression and anxiety. According to The Centers for Disease Control and Prevention study of Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic, "63 percent of young people reported experiencing substantial symptoms of anxiety and depression".

References

  1. ↑ Convergence Mental Health: A Transdisciplinary Approach to Innovation (First ed.). Oxford, New York: Oxford University Press. 19 January 2021. ISBN   978-0-19-750627-1.
  2. ↑ "Dr Harris Eyre". findanexpert.unimelb.edu.au.
  3. ↑ "Harris Eyre MD PhD". Archived from the original on 16 September 2020. Retrieved 15 September 2020.
  4. ↑ "Q&A with Dr. Harris Eyre, Psychiatry Trainee, Pharmacogeneticist • Student Doctor Network". 12 March 2018.
  5. ↑ "Brain capital profiled at United Nations General Assembly and in global public and private reports". 29 September 2022.
  6. ↑ Eyre, Harris (31 January 2024). "The Brain Economy: Advancing Brain Science to Better Understand the Modern Economy" (PDF). Malaysian Journal of Medical Science. 31 (1): 1–13. doi:10.21315/mjms2024.31.1.1. PMC   10917588 . PMID   38456111.
  7. ↑ Moose, Andy (9 September 2024). "Brain gain: How improving brain health benefits the economy". World Economic Forum. Retrieved 27 October 2024.
  8. ↑ "Our position on brain health". www.lundbeck.com. Retrieved 25 July 2023.
  9. ↑ "Optimizing brain health across the life course: WHO position paper". www.who.int. Retrieved 25 July 2023.
  10. 1 2 "Harris Eyre". Forbes.
  11. 1 2 "Dr Harris Eyre: a multi-faceted career while at UCLA". 21 September 2015.
  12. ↑ Abbott, Ryan; Chang, Donald D.; Eyre, Harris A.; Bousman, Chad A.; Merrill, David; Lavretsky, Helen (16 February 2018). "Pharmacogenetic Decision Support Tools: A New Paradigm for Late-Life Depression?". The American Journal of Geriatric Psychiatry. 26 (2): 125–133. doi:10.1016/j.jagp.2017.05.012. PMC   5812821 . PMID   29429869.
  13. ↑ Eyre, Harris; Baune, Bernhard; Lavretsky, Helen (16 September 2015). "Clinical advances in geriatric psychiatry: a focus on prevention of mood and cognitive disorders". The Psychiatric Clinics of North America. 38 (3): 495–514. doi:10.1016/j.psc.2015.05.002. PMC   4548274 . PMID   26300035.
  14. ↑ Eyre, Harris A.; Singh, Ajeet B.; Reynolds, Charles (16 February 2016). "Tech giants enter mental health". World Psychiatry. 15 (1): 21–22. doi:10.1002/wps.20297. PMC   4780298 . PMID   26833598.
  15. 1 2 Eyre, Harris A.; Lavretsky, Helen; Forbes, Malcolm; Raji, Cyrus; Small, Gary; McGorry, Patrick; Baune, Bernhard T.; Reynolds, Charles (16 February 2017). "Convergence Science Arrives: How Does It Relate to Psychiatry?". Academic Psychiatry. 41 (1): 91–99. doi:10.1007/s40596-016-0496-0. PMC   5540327 . PMID   26964782.
  16. ↑ Eyre, Harris A.; Becker, Elisabeth R.B.; Blumenthal, Marissa S.; Singh, Ajeet B.; Raji, Cyrus; Vahabzadeh, Arshya; Wainer, Zoe; Bousman, Chad (2020). "Consumer participation in personalized psychiatry". Personalized Psychiatry. pp. 63–68. doi:10.1016/B978-0-12-813176-3.00006-7. ISBN   9780128131763. S2CID   214120323.
  17. ↑ Eyre, Harris A.; Mitchell, Rob D.; Milford, Will; Vaswani, Nitin; Moylan, Steven (26 June 2014). "Portfolio careers for medical graduates: implications for postgraduate training and workforce planning". Australian Health Review. 38 (3): 246–251. doi:10.1071/AH13203. PMID   24718035 – via www.publish.csiro.au.
  18. ↑ "The brain economy". 4 February 2021.
  19. 1 2 "Build brains better: A proposal for a White House Brain Capital Council to accelerate post-COVID recovery and resilience". 22 December 2021.
  20. ↑ Ternes, Kylie; Iyengar, Vijeth; Lavretsky, Helen; Dawson, Walter; Booi, Laura; Ibanez, Agustin; Vahia, Ipsit; Reynolds, Charles; DeKosky, Steven; Cummings, Jeffrey; Miller, Bruce; Perissinotto, Carla; Kaye, Jeffrey; Eyre, Harris (1 February 2020). "Brain Health INnovation Diplomacy: a Model Binding Diverse Disciplines to Manage the Promise and Perils of Technological Innovation". International Psychogeriatrics. 32 (8): 955–979. doi:10.1017/s1041610219002266. PMC   7423685 . PMID   32019621.
  21. ↑ "'My migraines are a super power' – Harris A. Eyre MD PhD – EFNA". 16 May 2023.
  22. ↑ Eyre, H (May 2024). "The Brain Economy is an Inclusive Economy" (PDF). European Federation of Neurological Associations. Retrieved 27 October 2024.
  23. ↑ "Medical school opens a world of opportunities and success". Daily Mercury.
  24. ↑ "Whitsunday Anglican School Honours 2024 Old Scholar Award Recipients". Mackay and Whitsunday Life. 24 October 2024. Retrieved 27 October 2024.
  25. 1 2 "Dr Harris Eyre". www.jcu.edu.au. 26 April 2020.
  26. ↑ "Study a Bachelor's Degree of Medicine & Surgery in Queensland". www.jcu.edu.au.
  27. ↑ Eyre, Harris Anthony (2016). Novel approaches to the pathophysiology of late-life depression (Thesis). doi:10.25909/5b3d8feb48000. hdl:2440/113319.
  28. ↑ "Fulbright Scholar to focus on age-related decline". www.adelaide.edu.au.
  29. ↑ "Australian Fulbright Alumni Association (AFAA) - WG Walker Fund". fulbrightalumni.org.au.
  30. ↑ "Harris A. Eyre".
  31. ↑ "Harris Eyre, MBBS, PhD". 9 December 2021.
  32. ↑ "Harris Eyre".
  33. ↑ "Brain capital: A new vector for democracy strengthening". Brookings. Retrieved 25 July 2023.
  34. ↑ "Launch event of the Brain Capital Alliance: Towards Person-Centred Approach to Brain Health". CEPS. 17 June 2022. Retrieved 25 July 2023.
  35. ↑ Ibanez, Agustin (8 May 2024). "Scientists Explore the Global One Health Goals to Stop and Reverse the Loss of Brain Capital". Global Brain Health Institute. Retrieved 27 October 2024.
  36. 1 2 3 Convergence Mental Health: A Transdisciplinary Approach to Innovation. Oxford University Press. 19 January 2021. ISBN   978-0-19-750627-1.
  37. 1 2 Eyre, Harris A.; Berk, Michael; Lavretsky, Helen (19 January 2021). Convergence Mental Health: A Transdisciplinary Approach to Innovation. Oxford University Press. ISBN   978-0-19-750627-1.
  38. ↑ Eyre, Harris (24 October 2024). "Brain Science is the Foundation of the Brain Economy Transformation". Canadian Science Policy Centre. Retrieved 27 October 2024.
  39. 1 2 Smith, Erin; Ali, Diab; Wilkerson, Bill; Dawson, Walter D.; Sobowale, Kunmi; Reynolds, Charles; Berk, Michael; Lavretsky, Helen; Jeste, Dilip; Ng, Chee H.; Soares, Jair C.; Aragam, Gowri; Wainer, Zoe; Manji, Husseini K.; Licinio, Julio; Lo, Andrew W.; Storch, Eric; Fu, Ernestine; Leboyer, Marion; Tarnanas, Ioannis; Ibanez, Agustin; Manes, Facundo; Caddick, Sarah; Fillit, Howard; Abbott, Ryan; Robertson, Ian H.; Chapman, Sandra B.; Au, Rhoda; Altimus, Cara M.; Hynes, William; Brannelly, Patrick; Cummings, Jeffrey; Eyre, Harris A. (26 October 2020). "A Brain Capital Grand Strategy: toward economic reimagination". Molecular Psychiatry. 26 (1): 3–22. doi:10.1038/s41380-020-00918-w. PMC   8244537 . PMID   33100330. S2CID   225063066.
  40. ↑ "Brain Capital: A new economic and investment approach". 26 October 2020.
  41. ↑ Eyre, Harris A.; Ayadi, Rym; Ellsworth, William; Aragam, Gowri; Smith, Erin; Dawson, Walter D.; Ibanez, Agustin; Altimus, Cara; Berk, Michael; Manji, Husseini K.; Storch, Eric A.; Leboyer, Marion; Kawaguchi, Naoko; Freeman, Michael; Brannelly, Patrick; Manes, Facundo; Chapman, Sandra B.; Cummings, Jeffrey; Graham, Carol; Miller, Benjamin F.; Sarnyai, Zoltan; Meyer, Retsina; Hynes, William (5 May 2021). "Building brain capital". Neuron. 109 (9): 1430–1432. doi:10.1016/j.neuron.2021.04.007. PMC   8240507 . PMID   33957073.
  42. ↑ "Scaling up brain health investing to boost societal resilience". 13 January 2021.
  43. ↑ "NAEC and Neuro - New Approaches for Economic Challenges".
  44. 1 2 "Brain Capital Grand Strategy: Towards Economic Re-imagination".
  45. 1 2 "Events - New Approaches for Economic Challenges".
  46. ↑ "NAEC virtual seminar on Rethinking Productivity: Insights from Neuroscience".
  47. ↑ Rethinking Productivity: Insights from Neuroscience OECD 10 June 2021
  48. ↑ "Brain Capital Alliance" . Retrieved 15 January 2024.
  49. ↑ Eyre, Harris (15 January 2024). "What is Brain Capital?". YouTube . Retrieved 17 March 2024.
  50. ↑ "Global Partnerships in Brain Research Event at Science Summit @ UNGA77". 16 January 2024. Retrieved 15 January 2024.
  51. ↑ Wharton Neuroscience Initiative Summit
  52. ↑ Women in Government Leadership and Innovation Summit
  53. ↑ "Building youth brain capital for a better European future".
  54. ↑ "Congressional Neuroscience Caucus Briefing Long Haul Neurological & Psychological Impacts of COVID19". YouTube . 18 May 2022.
  55. ↑ Addressing America’s crisis of despair and economic recovery: A call for a coordinated effort brookings.edu
  56. ↑ "Our position on brain health".
  57. ↑ "Optimizing brain health across the life course: WHO position paper".
  58. ↑ "Towards a European Brain Initiative".
  59. ↑ "Multiple crises halt progress as 9 out of 10 countries fall backwards in human development, UNDP report warns | United Nations Development Programme".
  60. ↑ "Brain Exports: Growing the Nigerian Economy".
  61. ↑ Occhipinti, Jo-An (1 March 2023). "Mental Wealth Initiative welcomes new acclaimed member". The University of Sydney. Retrieved 27 October 2024.
  62. ↑ "HEKA - Where Tech meets Brain Science". Newfund Capital - VC Firm. Retrieved 25 July 2023.
  63. ↑ "PRODEO". PRODEO.
  64. ↑ "Home". Prodeo Institute.
  65. ↑ "CNSdose | Genetic Testing | Home". cnsdose.com.
  66. ↑ Connection, The Victorian (18 June 2018). "CNSDose showcases DNA-guided depression treatment". connection.vic.gov.au.
  67. ↑ Commission, Australian Trade and Investment. "Copy of Codelco Procurement Program". Austrade.
  68. ↑ "CNSDose to Demonstrate Leading Genetic Technology for Prescribing Antidepressants at the American Psychiatric Association Annual Meeting". Benzinga.
  69. ↑ Peterson, Kim; Dieperink, Eric; Ferguson, Lauren; Anderson, Johanna; Helfand, Mark (16 September 2011). Evidence Brief: The Comparative Effectiveness, Harms, and Cost-effectiveness of Pharmacogenomics-guided Antidepressant Treatment versus Usual Care for Major Depressive Disorder. VA Evidence Synthesis Program Reports. Department of Veterans Affairs (US). PMID   27606389 – via PubMed.
  70. ↑ "Texas Medical Center Announces $25 Million TMC Venture Fund". 8 November 2017.
  71. ↑ "Melbourne Accelerator Program". www.themap.co.
  72. ↑ "Ex Trade Minister Andrew Robb to advise genetic testing startup CNSDose". 11 July 2016.
  73. ↑ "Intermountain Precision Genomics Announces DNA Based Test to Personalize Prescribing Medication | Intermountain Healthcare". 5 December 2018.
  74. ↑ "Ramsay Health Care".
  75. ↑ Marshe, Victoria S.; Islam, Farhana; MacIukiewicz, Malgorzata; Bousman, Chad; Eyre, Harris A.; Lavretsky, Helen; Mulsant, Benoit H.; Reynolds, Charles F.; Lenze, Eric J.; Müller, Daniel J. (2020). "Pharmacogenetic Implications for Antidepressant Pharmacotherapy in Late-Life Depression: A Systematic Review of the Literature for Response, Pharmacokinetics and Adverse Drug Reactions". The American Journal of Geriatric Psychiatry. 28 (6): 609–629. doi:10.1016/j.jagp.2020.01.007. PMID   32122803. S2CID   211832281.
  76. ↑ Bousman, C. A.; Arandjelovic, K.; Mancuso, S. G.; Eyre, H. A.; Dunlop, B. W. (2019). "Pharmacogenetic tests and depressive symptom remission: A meta-analysis of randomized controlled trials". Pharmacogenomics. 20 (1): 37–47. doi:10.2217/pgs-2018-0142. PMID   30520364. S2CID   54481199.
  77. ↑ "Harris Eyre - Google Scholar". scholar.google.com.au.
  78. ↑ "Toward a Comprehensive Brain Deal to Harness the Potential of Artificial Intelligence". Baker Institute. Retrieved 25 July 2023.
  79. ↑ "Brain Capital is Key to a Sustainable Future". Baker Institute. Retrieved 25 July 2023.
  80. ↑ "Introducing the 'Neuroshield' — A Policy Approach to Protect Citizens from the Risks of AI". Baker Institute. Retrieved 25 July 2023.
  81. ↑ "Editorial Message and Issue Highlights–Vol. 18, No. 4–6, April–June 2021". June 2021.
  82. ↑ Eyre, Harris A; Ellsworth, William; Fu, Ernestine; Manji, Husseini K; Berk, Michael (September 2020). "Responsible innovation in technology for mental health care". The Lancet Psychiatry. 7 (9): 728–730. doi:10.1016/S2215-0366(20)30192-9. PMC   7440881 . PMID   32828153.
  83. ↑ "Modern Capitalism Must Prioritize Our Minds and Brains". 22 July 2021.
  84. ↑ "Closing the Brain Health Gap: Addressing women's inequalities". 21 August 2021.
  85. ↑ "Addressing the Cognition Crisis in Our COVID-19 World". 19 July 2021.
  86. ↑ Eyre, Harris A; Robb, Andrew; Abbott, Ryan; Hopwood, Malcolm (1 May 2019). "Mental health innovation diplomacy: An under-recognised soft power". Australian & New Zealand Journal of Psychiatry. 53 (5): 474–475. doi:10.1177/0004867419828488. PMID   30754995. S2CID   73438388.
  87. ↑ Ternes, Kylie; Iyengar, Vijeth; Lavretsky, Helen; Dawson, Walter D.; Booi, Laura; Ibanez, Agustin; Vahia, Ipsit; Reynolds, Charles; DeKosky, Steven; Cummings, Jeffrey; Miller, Bruce; Perissinotto, Carla; Kaye, Jeffrey; Eyre, Harris A. (13 February 2020). "Brain health INnovation Diplomacy: a model binding diverse disciplines to manage the promise and perils of technological innovation". International Psychogeriatrics. 32 (8): 955–979. doi:10.1017/S1041610219002266. PMC   7423685 . PMID   32019621.
  88. ↑ Chang, Donald D.; Storch, Eric A.; Black, Lance; Berk, Michael; Pellis, Neal; Lavretsky, Helen; Sutton, Jeffrey; Ternes, Kylie; Shepanek, Marc; Smith, Erin; Abbott, Ryan; Eyre, Harris A. (1 September 2020). "Promoting Tech Transfer Between Space and Global Mental Health". Aerospace Medicine and Human Performance. 91 (9): 737–745. doi:10.3357/AMHP.5589.2020. PMID   32867906. S2CID   221404577.
  89. ↑ Eyre, H. A.; Stuart, M. J.; Baune, B. T. (3 October 2014). "A phase-specific neuroimmune model of clinical depression". Progress in Neuro-Psychopharmacology & Biological Psychiatry. 54: 265–274. doi:10.1016/j.pnpbp.2014.06.011. PMID   24999185. S2CID   207410761.
  90. ↑ Eyre, Harris A.; Air, Tracy; Pradhan, Alyssa; Johnston, James; Lavretsky, Helen; Stuart, Michael J.; Baune, Bernhard T. (4 July 2016). "A meta-analysis of chemokines in major depression". Progress in Neuro-psychopharmacology & Biological Psychiatry. 68: 1–8. doi:10.1016/j.pnpbp.2016.02.006. PMC   5536843 . PMID   26903140.
  91. ↑ Bousman, Chad A.; Arandjelovic, Katarina; Mancuso, Serafino G.; Eyre, Harris A.; Dunlop, Boadie W. (16 January 2019). "Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials". Pharmacogenomics. 20 (1): 37–47. doi:10.2217/pgs-2018-0142. PMID   30520364. S2CID   54481199.
  92. ↑ Eyre, Harris A.; Siddarth, Prabha; Acevedo, Bianca; Van Dyk, Kathleen; Paholpak, Pattharee; Ercoli, Linda; St Cyr, Natalie; Yang, Hongyu; Khalsa, Dharma S.; Lavretsky, Helen (16 April 2017). "A randomized controlled trial of Kundalini yoga in mild cognitive impairment". International Psychogeriatrics. 29 (4): 557–567. doi:10.1017/S1041610216002155. PMC   5540331 . PMID   28088925.
  93. ↑ "U238794".
  94. ↑ "About".
  95. ↑ "International Advisory Board".
  96. ↑ "Yoga May Be Good for the Brain". June 2016.
  97. ↑ Post, Special to Financial (20 September 2021). "Why the fight against COVID-19 won't end with a high vaccination rate". Financial Post.
  98. ↑ "Inez Jabalpurwala: Long COVID contributing to brain health crisis disrupting labour force, economy". Financial Post. 27 May 2022.
  99. ↑ "The Brain of an Entrepreneur". 9 December 2021.
  100. ↑ "Preventing market failure in brain health: Moving toward fixes in investment, operations, and governance". 9 November 2021.
  101. ↑ "Ex Trade Minister Andrew Robb to advise genetic testing startup CNSDose". Australian Financial Review. 11 July 2016.
  102. ↑ Greene, Megan (12 August 2021). "Boosting brain health is key to a thriving economy". Financial Times.
  103. ↑ Univision. "Escudos contra desinformación: así buscan combatir la información falsa promovida por la inteligencia artificial". Univision (in Spanish). Retrieved 25 July 2023.
  104. ↑ "How social media is changing our brains". Dallas News. 5 December 2021. Retrieved 25 July 2023.
  105. ↑ "La science et la tech au chevet de la santé mentale au travail". 9 June 2022.
  106. ↑ "Whitsunday Anglican School Honours 2024 Old Scholar Award Recipients". Mackay and Whitsunday Life. 24 October 2024. Retrieved 27 October 2024.
  107. ↑ Consortium, Inclusive Economy. "Inclusive Economy Consortium". Inclusive Economy Consortium. Retrieved 12 June 2024.
  108. ↑ "Australian American Chamber of Commerce SF - Innovation Awards". www.sfaussies.com.
  109. ↑ Choahan, Neelima (22 October 2017). "Samuel Johnson among nominees for Victorian Australian of the Year awards". The Age.
  110. ↑ "Doctor Q November 2013". Issuu. 31 October 2013.
  111. ↑ "Build Back Brainier: Base Policies on Brain Science". A Systemic Recovery. New Approaches to Economic Challenges. 2022. doi:10.1787/1e893170-en. ISBN   978-92-64-64301-7.
  112. ↑ Dawson, Walter D.; Smith, Erin; Booi, Laura; Mosse, Maia; Lavretsky, Helen; Reynolds, Charles F.; Cummings, Jeffrey; Brannally, Patrick; Hynes, William; Lenze, Eric J.; Manes, Facundo; Ayadi, Rym; Frank, Lori; Chapman, Sandra Bond; Robertson, Ian H.; Rubenstein, Lori; Jraissati, Jorge; Ibáñez, Agustin; Fillit, Howard; Jeste, Dilip V.; Rao, Anitha; Berk, Michael; Storch, Eric A.; Santuccione Chadha, Antonella; Eyre, Harris A. (2022). "Investing in Late-Life Brain Capital". Innovation in Aging. pp. igac016. doi:10.1093/geroni/igac016. PMC   9116879 . PMID   35602311.
  113. ↑ Eyre, Harris (14 March 2024). "Brain capital is the new oil boom".
  114. ↑ "Strengthen brain health, strengthen the country". 15 April 2023.
  115. ↑ "Violence against women and acquired brain injuries". 12 April 2022.
  116. ↑ "How social media is changing our brains". 5 December 2021.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.